|
COMMERCE BUSINESS DAILY ISSUE OF JUNE 15,1999 PSA#2367Contract Management Branch, National Institute of Neurological
Disorders and Stroke, Neuroscience Center, Suite 3287, 6001 Executive
Blvd., MSC 9531, Bethesda, Maryland 20892-9531 A -- HIGH THROUGHPUT ANALYSIS OF GENE EXPRESSION PATTERNS IN THE
NERVOUS SYSTEM SOL NINDS-99-RFI-02 DUE 070699 POC Laurie Leonard,
Contracting Officer, (301) 496-1813 E-MAIL: Laurie Leonard,
ll44s@nih.gov. The National Institute of Neurological Disorders and
Stroke (NINDS) and National Institute of Mental Health (NIMH) are
planning to establish a public gene expression database for the mouse
nervous system. As part of this initiative, we are seeking sources that
are interested in and capable of high throughput production of
histological data on gene product localization in tissue sections of
the brain and spinal cord. Background This RFI is issued as one element
of the Brain Molecular Anatomy Project (BMAP), a multi-institute
initiative aimed at promoting the understanding of gene function in the
nervous system. BMAP has two components: (1) gene discovery, and (2)
gene expression analysis. The gene discovery component is using an
expressed sequence tag (EST) sequencing approach to catalogue the full
repertoire of genes that are expressed in the nervous system under
both normal and abnormal conditions. This gene discovery component of
BMAP was initiated last year, with the award of a contract (N01
MH80014) to the University of Iowa (M. B. Soares, PI) to support
construction of cDNA libraries from 11 brain regions of adult mouse.
Over 75,000 3' ESTs will be derived from serially subtracted libraries,
and used to identify a non-redundant collection of >20,000 mouse
brain cDNAs. The expression analysis component of BMAP will use high
throughput methods to analyse gene expression patterns in the nervous
system as a function of cell type, anatomical location, developmental
stage, and physiological state. The first step in this analysis
component was the issuance of a Request for Applications (NS-99-003) to
develop technologies to support gene expression analysis in the nervous
system. The next step will be to establish a public database of images
of gene expression patterns in sections of the mouse brain and spinal
cord. To aid in the design of a possible future solicitation relative
to this initiative, we ask that interested organizations submit
information concerning your capabilities to accomplish the following:
1. Generation of histochemical probes for hundreds to thousands of gene
products (RNA and/or protein) normally expressed in the murine nervous
system. (Note: The 20,000 member mouse brain cDNA collection described
above will be available for this effort.) 2. High throughput production
of tissue sections of uniform thickness and consistent stereotaxic
position from the mouse brain and spinal cord. 3. Histochemical
processing of tissue sections to localize RNA and/or protein products
at high sensitivity, resolution, and throughput volume. 4. Collection
of microscopic, microscanner, or other kinds of optical images of gene
localization patterns in tissue sections for subsequent transfer into
an image database. It is our opinion that the most suitable target
audience to respond to this initiative would be organizations involved
in high throughput generation of histological data. This Request for
Information (RFI) is for information and planning purposes only and
shall not be construed as a solicitation or as an obligation on the
part of the Government. The Government does not intend to award a
contract on the basis of responses nor otherwise pay for the
preparation of any information submitted or the Government's use of
such information. Acknowledgment of receipt of responses will not be
made, nor will respondents be notified of the Government's evaluation
of the information received. However, should such a requirement
materialize, no basis for claims against the Government shall arise as
a result of a response to this request for information or the
Government's use of such information as either part of our evaluation
process or in developing specifications for any subsequent requirement.
Responses will be held in a confidential manner. Any proprietary
information should be so marked. All respondents are asked to indicate
the type and size of your business organization, e.g., Large Business,
Small Business, Hubzone Small Business, Small Disadvantaged Business,
Women-Owned Business, 8(a), Historically Black College or
University/Minority Institution (HBCU/MI), educational institution,
profit/non-profit hospital, or other nonprofit organization. Responses
should be identified with NINDS RFI No. 99-02, and are due by July 6,
1999. Please submit three (3) copies of your response, not to exceed
5 pages, to the attention of: Laurie A. Leonard, Contracting Officer,
Contracts Management Branch, National Institute of Neurological
Disorders and Stroke, NIH, 6001 Executive Boulevard, Room 3287, MSC
9531, Bethesda, Maryland 20892-9531. Facsimile responses will also be
accepted as long as they do not exceed 5 pages in length. E-mail
responses, sent to LL44S@nih.gov, will also be accepted. Posted
06/11/99 (W-SN342046). (0162) Loren Data Corp. http://www.ld.com (SYN# 0011 19990615\A-0011.SOL)
A - Research and Development Index Page
|
|